2015 Featured Speakers

  • Nadeem SarwarVP & Head, Genetics & Human Biology Eisai

  • Kiran ReddyAssociate Partner Third Rock Ventures

  • Gabriel VargasExecutive Medical Director Amgen

  • Dario DollerDirector, Discovery Chemistry & DMPK Lundbeck

Enhance your Preclinical Modeling & Biomarker Development Strategies to Improve your CNS Drug Discovery Success

23 speakers. 26 sessions. 1 CNS Leader's Forum. 5 Interactive Sessions. 10 hours of Networking. World CNS 2015 is here.

This year the agenda has been put together to focus on providing you with the key information to improve the predictive validity of your preclinical models and biomarkers.

Designed to build on the collaboration of previous years and drive the forward movement for the industry, leading drug developers such as Pfizer, Amgen, Eisai and Abbvie will be here, sharing their honest insights and experiences. Attend and you will discover how you can strengthen CNS drug development and gain practical advice on how to ultimately de-risk your clinical trials.

Here's a snapshot of what you will learn:

  • Identify novel physiological biomarkers by hearing about the latest techniques for discovery and validation
  • Learn how success was found in obesity research and how we can try and implement these best practices
  • Gain insight on challenges faced in taking a drug target from the lab to the clinic successfully
  • Learn about the alternatives to live animal models that could enhance your preclinical data
  • Deliver on the promise of new CNS drug therapies by pushing the industry forward through knowledge sharing, collaborations and partnerships

Download the brochure to learn more about how World CNS 2015 will provide the right environment for a collaborative approach to clinical success? 

“The talks were high quality and the interaction among the participants was excellent”

Genentech